Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
IGEN Networks Corp. (IGEN)
USD0.00
+0.00 (+0.00%)
US OTC Technology Software - Application
Address
31772 Casino Drive 92530
Lake Elsinore, CA, US
Lake Elsinore, CA, US
CEO
Neil Gene Chan
Website
igen-networks.com
IPO
2009-07-24
CIK 1393540 ISIN US45172B1026
Also trades on
Canadian Securities Exchange · IGN.CN (CAD)
Other OTC · IGEN (USD)
Description
Operating within the United States, IGEN Networks Corp. specializes in creating and distributing software solutions tailored for the automotive and fleet management sectors. Its core offerings include systems for vehicle tracking and retrieval, alongside platforms that grant secure, direct insights into both vehicle performance data and driver conduct. These services are made available to a diverse clientele, encompassing automotive dealerships, financial organizations, and individual consumers, distributed through a range of commercial and direct-to-consumer labels. Initially established as Sync2 Entertainment Corporation, the company adopted the name IGEN Networks Corp. in June of 2009. Founded in 2006, its primary offices are located in Lake Elsinore, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
652.2K
Beta
-0.02
Float Shares
3.05B
Free Float %
94.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | +0.00% | -99.89% | -99.99% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-1,050.08
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Software - Application: +13.0%+18.2% ★ Q3'23: -63.6% (vs Q3'22)
-
EPS growth Software - Application: +28.6%+76.7% ★ Q3'23: +50.0% (vs Q3'22)
-
FCF margin FCF growth · Software - Application: +45.3%-254.8% Q3'23: -54.3% (vs Q3'22)
-
EBIT margin Software - Application: +9.4%-226.3% Q3'23: -276.6% (vs Q3'22)
-
ROIC Software - Application: +7.5%-6,877.1% Q3'23: +111.1% (vs Q3'22)
-
Share dilution Software - Application: +0.0%+27.7% Q3'23: +50.2% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-1.22× Q3'23: -1.78× (vs Q3'22)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-380.8K
OE per share TTM
0.00
Owner's Yield
-155.73%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
2.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
700.0K
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+700,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-20 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 150,000 | 0.01 | 765.00 | 27,726,911 | — | ↗ |
| 2020-11-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.01 | 1.1K | 27,576,911 | — | ↗ |
| 2020-11-18 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 150,000 | 0.00 | 720.00 | 27,376,911 | — | ↗ |
| 2020-10-01 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.01 | 1.6K | 27,226,911 | — | ↗ |
| 2020-09-30 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.01 | 1.7K | 27,026,911 | — | ↗ |
| 2020-07-31 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.01 | 1.5K | 26,826,911 | — | ↗ |
| 2020-06-03 | Sierra Abel Israel Sr | Officer | P-Purchase | A | Common Stock | 10,000,000 | 0.00 | 25.0K | 10,170,000 | — | ↗ |
| 2020-06-01 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 16,828,800 | 0.00 | 42.1K | 26,626,911 | — | ↗ |
| 2020-04-17 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500,000 | 0.01 | 4.0K | 9,798,111 | — | ↗ |
| 2020-04-16 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500,000 | 0.01 | 4.5K | 9,298,111 | — | ↗ |
| 2020-04-15 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000,000 | 0.01 | 14.0K | 8,798,111 | — | ↗ |
| 2020-04-14 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 1,000,000 | 0.01 | 7.0K | 6,798,111 | — | ↗ |
| 2020-04-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 1,000,000 | 0.00 | 1.0K | 5,798,111 | — | ↗ |
| 2020-04-08 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500,000 | 0.00 | 600.00 | 4,798,111 | — | ↗ |
| 2020-03-27 | Friedman Robert G | Director / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 25,000,000 | — | ↗ |
| 2020-03-23 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500,000 | 0.00 | 550.00 | 4,298,111 | — | ↗ |
| 2020-03-20 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500,000 | 0.00 | 750.00 | 3,798,111 | — | ↗ |
| 2020-02-24 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 0.01 | 1.0K | 3,298,111 | — | ↗ |
| 2020-02-21 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 300,000 | 0.01 | 1.9K | 3,098,111 | — | ↗ |
| 2020-02-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.01 | 475.00 | 2,798,111 | — | ↗ |
| 2020-02-18 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.01 | 850.00 | 2,748,111 | — | ↗ |
| 2020-02-13 | Nealon Robert | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-02-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.01 | 500.00 | 2,648,111 | — | ↗ |
| 2020-02-11 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.01 | 1.1K | 2,598,111 | — | ↗ |
| 2020-02-07 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.01 | 1.4K | 2,498,111 | — | ↗ |
| 2020-02-06 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.01 | 700.00 | 2,398,111 | — | ↗ |
| 2019-12-20 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.02 | 450.00 | 2,348,111 | — | ↗ |
| 2019-12-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.02 | 450.00 | 2,323,111 | — | ↗ |
| 2019-12-17 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.02 | 1.8K | 2,298,111 | — | ↗ |
| 2019-12-16 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.02 | 475.00 | 2,198,111 | — | ↗ |
| 2019-12-11 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.03 | 625.00 | 2,173,111 | — | ↗ |
| 2019-12-10 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.03 | 250.00 | 2,148,111 | — | ↗ |
| 2019-12-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.03 | 1.3K | 2,138,111 | — | ↗ |
| 2019-12-04 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.31 | 7.8K | 2,088,111 | — | ↗ |
| 2019-12-03 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.30 | 7.5K | 2,063,111 | — | ↗ |
| 2019-11-20 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.03 | 155.00 | 2,038,111 | — | ↗ |
| 2019-11-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.03 | 170.00 | 2,033,111 | — | ↗ |
| 2019-11-18 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 30,000 | 0.04 | 1.1K | 1,978,111 | — | ↗ |
| 2019-10-31 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.04 | 190.00 | 1,948,111 | — | ↗ |
| 2019-10-29 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.03 | 600.00 | 1,868,111 | — | ↗ |
| 2019-10-28 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.04 | 200.00 | 1,848,111 | — | ↗ |
| 2019-08-29 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.06 | 600.00 | 1,843,111 | — | ↗ |
| 2019-08-28 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.04 | 780.00 | 1,833,111 | — | ↗ |
| 2019-08-23 | Chan Neil Gene | Director / Officer | S-Sale | D | Common Stock | 20,000 | 0.05 | 900.00 | 1,813,111 | — | ↗ |
| 2019-08-21 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.04 | 400.00 | 1,833,111 | — | ↗ |
| 2019-02-21 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 45,000 | 0.04 | 1.8K | 1,823,111 | — | ↗ |
| 2019-02-15 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.04 | 1.8K | 1,778,111 | — | ↗ |
| 2019-02-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.04 | 1.0K | 1,728,111 | — | ↗ |
| 2019-01-17 | Chan Neil Gene | Director / Officer | J-Other | D | Common Stock | 300,000 | 0.00 | — | 1,678,111 | — | ↗ |
| 2019-01-09 | Chan Neil Gene | Director / Officer | J-Other | D | Common Stock | 365,356 | 0.00 | — | 1,978,111 | — | ↗ |
| 2018-11-08 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.06 | 119.80 | 2,331,967 | — | ↗ |
| 2018-11-06 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.09 | 180.00 | 2,329,967 | — | ↗ |
| 2018-11-05 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.06 | 305.00 | 2,338,967 | — | ↗ |
| 2018-10-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.08 | 160.00 | 2,320,467 | — | ↗ |
| 2018-08-31 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.08 | 400.00 | 2,315,467 | — | ↗ |
| 2018-08-30 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.07 | 325.00 | 2,310,467 | — | ↗ |
| 2018-08-16 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 500 | 0.07 | 35.00 | 2,305,467 | — | ↗ |
| 2018-08-15 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.07 | 325.00 | 2,302,967 | — | ↗ |
| 2018-08-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.06 | 142.50 | 2,292,967 | — | ↗ |
| 2018-08-08 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.05 | 127.50 | 2,285,467 | — | ↗ |
| 2018-07-17 | Sierra Abel Israel Sr | Officer | P-Purchase | A | Common Stock | 20,000 | 0.04 | 800.00 | 170,000 | — | ↗ |
| 2018-07-16 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.06 | 275.00 | 2,277,967 | — | ↗ |
| 2018-06-29 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.07 | 350.00 | 2,262,967 | — | ↗ |
| 2018-06-27 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.04 | 400.00 | 2,257,967 | — | ↗ |
| 2018-06-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.04 | 400.00 | 2,257,967 | — | ↗ |
| 2018-04-06 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.12 | 287.50 | 2,247,967 | — | ↗ |
| 2018-04-05 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.06 | 600.00 | 2,245,467 | — | ↗ |
| 2018-03-23 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.06 | 300.00 | 2,235,467 | — | ↗ |
| 2018-03-22 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.06 | 300.00 | 2,230,467 | — | ↗ |
| 2018-03-21 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.12 | 230.00 | 2,225,467 | — | ↗ |
| 2018-01-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.10 | 499.00 | 2,223,467 | — | ↗ |
| 2018-01-09 | Chan Neil Gene | Director / Officer | J-Other | D | Common Stock | 343,200 | 0.00 | — | 2,218,467 | — | ↗ |
| 2018-01-04 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.12 | 597.00 | 2,561,667 | — | ↗ |
| 2017-12-15 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.07 | 140.00 | 2,556,667 | — | ↗ |
| 2017-12-04 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.12 | 230.00 | 2,552,667 | — | ↗ |
| 2017-11-29 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.10 | 200.00 | 2,550,667 | — | ↗ |
| 2017-11-28 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.10 | 200.00 | 2,548,667 | — | ↗ |
| 2017-09-21 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.09 | 212.50 | 2,546,667 | — | ↗ |
| 2017-09-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.11 | 285.00 | 2,544,167 | — | ↗ |
| 2017-09-15 | Sierra Abel Israel Sr | Officer | — | D | Common Stock | 0 | 0.00 | — | 150,000 | — | ↗ |
| 2017-09-15 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 0.08 | 150.00 | 2,539,167 | — | ↗ |
| 2017-09-14 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.07 | 1.3K | 2,537,167 | — | ↗ |
| 2017-09-01 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 11,000 | 0.09 | 935.00 | 2,514,167 | — | ↗ |
| 2017-06-14 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.10 | 1.0K | 2,553,167 | — | ↗ |
| 2017-05-11 | Sierra Abel Israel Sr | Officer | — | D | Stock Options | 150,000 | 0.13 | 19.5K | 0 | — | ↗ |
| 2017-05-11 | Freeman Richard Allan | Director / Officer | A-Award | A | Options | 500,000 | 0.13 | 65.0K | 1,775,000 | — | ↗ |
| 2017-05-11 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 6,000 | 0.13 | 780.00 | 2,543,167 | — | ↗ |
| 2017-05-10 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 0.13 | 520.00 | 2,549,167 | — | ↗ |
| 2017-04-19 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 0.12 | 307.50 | 2,550,667 | — | ↗ |
| 2017-04-18 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.13 | 650.00 | 2,548,167 | — | ↗ |
| 2017-01-18 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.10 | 475.00 | 2,523,167 | — | ↗ |
| 2017-01-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 25,000 | 0.06 | 1.5K | 2,513,167 | — | ↗ |
| 2017-01-06 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 10,000 | 0.07 | 749.00 | 2,488,167 | — | ↗ |
| 2016-12-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.07 | 700.00 | 2,478,167 | — | ↗ |
| 2016-12-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 0.10 | 1.0K | 2,468,167 | — | ↗ |
| 2016-09-26 | Chan Neil Gene | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 25,000 | 0.09 | 2.3K | 2,458,167 | — | ↗ |
| 2016-07-21 | Sierra Abel Israel Sr | Officer | — | D | Stock Options | 150,000 | 0.16 | 24.0K | 0 | — | ↗ |
| 2016-07-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 5,000 | 0.14 | 690.00 | 2,433,167 | — | ↗ |
| 2016-05-05 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 10,000 | 0.16 | 1.6K | 2,428,167 | — | ↗ |
| 2016-02-12 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 10,000 | 0.18 | 1.8K | 2,418,167 | — | ↗ |
| 2016-02-10 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 10,000 | 0.18 | 1.8K | 2,408,167 | — | ↗ |
| 2016-02-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common | 10,000 | 0.17 | 1.7K | 2,398,167 | — | ↗ |
| 2016-01-07 | Chan Neil Gene | Director / Officer | M-Exempt | A | Common | 55,556 | 0.09 | 5.0K | 2,388,167 | — | ↗ |
| 2015-09-21 | Nealon Robert | Director | A-Award | A | Options | 250,000 | 0.19 | 47.5K | 250,000 | — | ↗ |
| 2015-09-21 | Freeman Richard Allan | Director / Officer | A-Award | A | Options | 1,000,000 | 0.19 | 190.0K | 1,000,000 | — | ↗ |
| 2015-09-21 | Chan Neil Gene | Director / Officer | A-Award | A | Options | 1,000,000 | 0.19 | 190.0K | 1,000,000 | — | ↗ |
| 2015-09-10 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 5,500 | 0.25 | 1.4K | 2,602,611 | — | ↗ |
| 2013-11-04 | Chan Neil Gene | Director / Officer | C-Conversion | D | Stock Option | 325,000 | 0.09 | 29.3K | 55,556 | — | ↗ |
| 2013-10-11 | Freeman Richard Allan | Director / Officer | C-Conversion | D | Stock Option | 225,000 | 0.09 | 20.3K | 275,000 | — | ↗ |
| 2013-03-26 | Chan Neil Gene | Director / Officer | M-Exempt | D | Options | 444,444 | 0.09 | 40.0K | 55,556 | — | ↗ |
| 2013-03-25 | Freeman Richard Allan | Director / Officer | A-Award | A | Stock Option | 500,000 | 0.09 | 45.0K | 500,000 | — | ↗ |
| 2013-03-25 | Chan Neil Gene | Director / Officer | A-Award | A | Options | 825,000 | 0.09 | 74.3K | 825,000 | — | ↗ |
| 2013-03-18 | Chan Neil Gene | Director / Officer | A-Award | A | Common Stock | 1,666,667 | 0.00 | — | 1,686,667 | — | ↗ |
| 2012-07-09 | Chan Neil Gene | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 5,999.15 | 119.98M | 20,000 | — | ↗ |
| 2011-11-01 | Freeman Richard Allan | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-10-12 | Nealon Robert | Director | P-Purchase | A | IGEN Common Stock | 20,000 | 0.30 | 6.0K | 521,571 | — | ↗ |
| 2011-09-01 | Chan Neil Gene | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2010-07-15 | Ormsby Monty | Director / Officer | A-Award | A | Stock Options | 350,000 | 0.70 | 245.0K | 350,000 | — | ↗ |
| 2010-07-15 | Nealon Robert | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.70 | 350.0K | 500,000 | — | ↗ |
| 2010-07-15 | Gilbertson Richard | Director / Officer | A-Award | A | Stock Options | 200,000 | 0.70 | 140.0K | 200,000 | — | ↗ |
| 2010-07-08 | Nealon Robert | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 500,000 | — | ↗ |
| 2010-05-27 | Shade Chris | Director | — | D | Common Stock | 0 | 0.00 | — | 250,000 | — | ↗ |
| 2010-05-27 | Gilbertson Richard | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 500,000 | — | ↗ |
| 2010-02-15 | Ormsby Monty | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 150,000 | — | ↗ |
| 2010-02-15 | Grudman Michael | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 400,000 | — | ↗ |
| 2004-02-13 | MIGAUSKY GEORGE V | Officer | D-Return | D | Option to Buy | 1,846 | 37.91 | 70.0K | 0 | — | ↗ |
| 2004-02-06 | MIGAUSKY GEORGE V | Officer | M-Exempt | D | Option to Buy | 20,000 | 5.00 | 100.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-720.00
Shares Outstanding
3.23B
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2016 | Richard Freeman - Director, COO | 120.6K | — | — | — | — | — | 120.6K | 0.00% | ↗ |
| 2 | 2016 | Neil G. Chan - Director, President & CEO | 120.6K | — | — | — | — | — | 120.6K | 0.00% | ↗ |
| 3 | 2015 | Neil G. Chan - Director, President & CEO | 98.3K | — | — | 189.9K | — | — | 288.2K | 65.90% | ↗ |
| 4 | 2015 | Richard Freeman - Director, COO | 86.5K | — | — | 189.9K | — | — | 276.4K | 68.69% | ↗ |
| 5 | 2014 | Neil G. Chan - Director, President & CEO | 74.4K | — | — | — | — | — | 74.4K | 0.00% | ↗ |
| 6 | 2014 | Richard Freeman - Director, COO | 65.2K | — | — | — | — | — | 65.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Neil Gene Chan | Chief Executive Officer, Chief Financial Officer & Director | 142.0K | male |
| Abel Israel Sierra | Chief Operating Officer & Director | 121.0K | male |
| Juan Ignacio Avila Diaz Rubin | Chief Technology Officer | — | male |
ESG Rating
ESG Score History SOFTWARE - APPLICATION
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IGEN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
